EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of training oncology physicians advising patients on complementary and integrative therapies on patient‐reported outcomes: 2‐year follow‐up of the multi‐center, cluster‐randomized KOKON‐KTO study

Alizé A Rogge iD, Stefanie M Helmer, Katja Icke, Claudia M Witt

Cancer Medicine · 2024

DOI: 10.1002/cam4.70008 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Alizé A Rogge und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosomatic Medicine, Center for Patient-Centered Outcomes Research, Charité-Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Complementary Therapies, Neoplasms, Physician-Patient Relations, Patient Reported Outcome Measures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Deutsche Krebshilfe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Many cancer patients wish for complementary and integrative medicine (CIM) consultations led by their oncology physician. Within the KOKON‐KTO study, oncology physicians in the intervention group were trained in a blended learning to provide CIM consultations to their cancer patients in addition to distributing a leaflet about CIM websites. Control oncology physicians only distributed the leaflet. The training showed positive effects on the patient‐level. As of now, no consistent evidence exists on the long‐term effects of such one‐time‐only CIM consultation during cancer treatment.

Methods

In the KOKON‐KTO follow‐up study, cancer patients previously participating in the KOKON‐KTO study (intervention group:IG and control group: CG) received, at least 24 months later, a follow‐up questionnaire by post, evaluating long‐term effects of the KOKON‐KTO consultation using the measures provided in the original study (patient‐physician communication (EORTC‐QLQ‐COMU2), satisfaction with cancer treatment (PS‐CaTE), CIM disclosure with healthcare provider (HCP), and need for CIM consultation during cancer therapy).

Results

In total, 102 cancer patients participated in the follow‐up study (IG n = 62; CG n = 40). The overall reponse rate was around 36% (IG: 48.4%; CG: 23.7%). In the follow‐up study, differences between groups had increased and were still shown (EORTC‐QLQ‐COMU26, 0–100 point scale, ≥10‐point‐group difference) in some subscales: patient's active behavior ( in means; IG:73.6 (95% CI, 63.8–83.5); CG:61.1 (95% CI, 52.4–69.8)); clinician‐patient relationship (IG:80.9 (95% CI, 71.8–90.0); CG:68.7 (95% CI, 59.3–78.0)). For some outcomes, differences decreased over time (e.g., EORTC‐QLQ‐COMU26 subscales “takes into account patient's preference” and “corrects misunderstandings”). More patients in the CG used CIM without oncology physicians' knowledge (IG: 13.7%, CG: 24.0%).

Conclusion

This study presents first findings that one‐time‐only CIM consultations may enhance patient‐physican relationship and CIM disclosure long‐term. To further support cancer patients' in their wish for CIM consultations, training programs should provide oncology physicians with CIM competencies for different cancer stages including cancer survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complementary TherapiesNeoplasmsPhysician-Patient RelationsPatient Reported Outcome MeasuresHumansFemaleMaleFollow-Up StudiesMiddle AgedPatient SatisfactionAgedIntegrative MedicineOncologistsReferral and ConsultationSurveys and QuestionnairesAdultPatient Education as TopicMedical Oncology

Stichwörter der Autor:innen

cancerfollow‐up studiesintegrative oncologyphysician‐patient communication

Autor:innen und Institutionen

  • Department of Psychosomatic Medicine, Center for Patient-Centered Outcomes Research, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Institute of Health and Nursing Science, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Institute of Public Health and Nursing Research, University of Bremen, Bremen, Germany.
  • Institute for Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Institute for Complementary and Integrative Medicine, University Zurich and University Hospital Zurich, Zurich, Switzerland.

ORCID-Profile: Alizé A Rogge

Förderung

  • Wellcome Trust
  • Deutsche Krebshilfe

Zitieren

APA

Rogge, A. A., Helmer, S. M., Icke, K., & Witt, C. M. (2024). Effects of training oncology physicians advising patients on complementary and integrative therapies on patient‐reported outcomes: 2‐year follow‐up of the multi‐center, cluster‐randomized KOKON‐KTO study. Cancer Medicine. https://doi.org/10.1002/cam4.70008

Vancouver

Rogge AA, Helmer SM, Icke K, Witt CM. Effects of training oncology physicians advising patients on complementary and integrative therapies on patient‐reported outcomes: 2‐year follow‐up of the multi‐center, cluster‐randomized KOKON‐KTO study. Cancer Medicine. 2024. doi:10.1002/cam4.70008

BibTeX
@article{Rogge2024,
  author = {Rogge, Alizé A and Helmer, Stefanie M and Icke, Katja and Witt, Claudia M},
  title = {Effects of training oncology physicians advising patients on complementary and integrative therapies on patient‐reported outcomes: 2‐year follow‐up of the multi‐center, cluster‐randomized KOKON‐KTO study},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70008}
}
Kostenlos starten →